Purpose: Retinoblastoma (RB) is the most common primary malignant intraocular tumor in children. Although systemic chemotherapy has been the primary treatment, intra-arterial chemotherapy (IAC) represents a new treatment option. Here, we performed alternate systemic chemotherapy and IAC and retrospectively reviewed the efficacy and safety of this approach
BACKGROUND: Intra-arterial (i.a.) chemotherapy has more risks of procedural complications in neonate...
Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young in...
Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young in...
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or ch...
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or ch...
Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. Although enucleation a...
Intra-arterial chemotherapy (IAC) for retinoblastoma treatment, also called superselective ophthalmi...
Intra-arterial chemotherapy (IAC) for retinoblastoma treatment, also called superselective ophthalmi...
Intra-arterial chemotherapy (IAC) for retinoblastoma treatment, also called superselective ophthalmi...
Treatment of intraocular retinoblastoma is challenging. It requires a multidisciplinary personalized...
The recent trend of treatment for retinoblastoma is to salvage the eye globes as well as achieving p...
Introduction. Retinoblastoma is the most common primary intraocular neoplasm in children. With the a...
The tools for managing retinoblastoma have been increasing in the past decade. While globe-salvage s...
AIM:To report our first three-and-a-half years' experience with intra-arterial chemotherapy (IAC) in...
Background: Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates ...
BACKGROUND: Intra-arterial (i.a.) chemotherapy has more risks of procedural complications in neonate...
Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young in...
Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young in...
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or ch...
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or ch...
Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. Although enucleation a...
Intra-arterial chemotherapy (IAC) for retinoblastoma treatment, also called superselective ophthalmi...
Intra-arterial chemotherapy (IAC) for retinoblastoma treatment, also called superselective ophthalmi...
Intra-arterial chemotherapy (IAC) for retinoblastoma treatment, also called superselective ophthalmi...
Treatment of intraocular retinoblastoma is challenging. It requires a multidisciplinary personalized...
The recent trend of treatment for retinoblastoma is to salvage the eye globes as well as achieving p...
Introduction. Retinoblastoma is the most common primary intraocular neoplasm in children. With the a...
The tools for managing retinoblastoma have been increasing in the past decade. While globe-salvage s...
AIM:To report our first three-and-a-half years' experience with intra-arterial chemotherapy (IAC) in...
Background: Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates ...
BACKGROUND: Intra-arterial (i.a.) chemotherapy has more risks of procedural complications in neonate...
Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young in...
Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young in...